After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

You may be debating whether or not you should get the COVID-19 vaccine during pregnancy, especially since there are conflicting guidelines and stories about whether or not it's recommended and safe ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

Italian tyre maker Pirelli is in a risky situation after its Chinese leading shareholder Sinochem rejected a proposal by the ...

The Centers for Disease Control and Prevention will no longer recommend that healthy children and pregnant women receive the COVID-19 vaccine, the Trump administration announced Tuesday. “Last ...

WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...